Live From

SupplySide Global

October 28, 2026 - October 30, 2026
|
Mandalay Bay, Las Vegas, NV
Sponsored By
SupplySide Global

Waleria Healthtech to Showcase Shatavari Studies on Perimenopause and Libido

The new research supports emerging health ingredients of the adaptogenic extract, marketed as aspurūs.

Author Image

By: Mike Montemarano

Associate Editor, Nutraceuticals World

Photo: Kiran | Adobe Stock

Booth 7324

Waleria Healthtech will provide a first look at new clinical findings from studies on aspurūs, a Shatavari root extract, which support its role in perimenopause symptom relief and libido in women.

Shatavari is an adaptogenic herb traditionally used in Ayurveda for women’s reproductive health, hormonal balance, and general wellness at various stages of menopause. The ingredient, aspurūs, is backed by pre-clinical and clinical data to support major menopause symptoms such as hot flashes, night sweats, stress, fatigue, and insomnia.

Perimenopausal Symptom Relief

A three-month randomized, double-blind, placebo-controlled study involving over 150 perimenopausal women demonstrated significant reduction in both intensity and frequency of multi-menopausal symptoms.

The results suggested notable improvement in hot flashes within four weeks, and other menopause symptoms, assessed via a scale that captures the frequency and severity across 12 domains of menopausal symptoms, according to Waleria.

The findings build on a 2024 study with similar findings on women with menopause, peri-menopause, and post-menopause.

Female Libido and Sexual Wellness

In a two-month, double-blind, placebo-controlled trial, aspurūs was studied at a lower-than-usual dose in reproductive-aged women experiencing reduced libido.

The results suggested higher frequency of sexual activity compared to the placebo group, and improvements in arousal, lubrication, orgasm, and overall sexual satisfaction after just four weeks, Waleria reported.

The study explored the connection between overall energy and libido; in reproductive age, a reduced sexual desire is often linked to fatigue, mood, and stress. This is among the first large-scale, placebo-controlled studies to show Shatavari’s role in supporting sexual wellness, the company noted.

“Our evidence is even stronger and more robust with three gold standard clinical studies for aspurūs,” said Komal Baldwa, founder of Waleria. “This level of clinical research for aspurūs sets a new benchmark for women’s health ingredients. By demonstrating benefits in perimenopausal symptom relief, menopausal quality of life, and female sexual wellness, aspurūs delivers a rigorously-studied, plant-based, and non-hormonal solution that formulators and consumers can trust.”

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters